OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Though Altman said he likely wouldn’t agree with Trump on “everything,” the OpenAI CEO said he believes “he will be ...

Elon Musk is clashing with OpenAI CEO Sam Altman over the Stargate artificial intelligence infrastructure project touted by ...

President Donald Trump spoke with OpenAI CEO Sam Altman by phone Friday, ahead of the AI infrastructure announcement, CNBC ...

Elon Musk, known for his outspoken opinions and high-profile feuds, has taken fresh aim at OpenAI CEO Sam Altman in a heated ...

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...

The feds have sided with Elon Musk on a key pillar of his high-profile antitrust lawsuit against Sam Altman-led OpenAI, Microsoft and billionaire Reid Hoffman, The Post has learned. In November ...

There was this whole thing of, like, “Sam didn’t even tell the ... to invest in AI-focused startups. 12 OpenAI’s current board is made up of Altman and: You obviously won, because you ...

OpenAI CEO Sam Altman has made several predictions about where we're headed on AGI, superintelligence, agentic AI — and when we might get there. Anthropic's latest funding round will place it ...

OpenAI CEO Sam Altman recently published a post on his personal blog reflecting on AI progress and his predictions for how the technology will impact humanity’s future. “We are now confident ...

OpenAI CEO Sam Altman says that the company is confident that it knows “how to build AGI as we have traditionally understood it,” referring to the tech industry’s long-sought benchmark of ...